Glycosphingolipid functions.

The combination of carbohydrate and lipid generates unusual molecules in which the two distinctive halves of the glycoconjugate influence the function of each other. Membrane glycolipids can act as primary receptors for carbohydrate binding proteins to mediate transmembrane signaling despite restriction to the outer bilayer leaflet. The extensive heterogeneity of the lipid moiety plays a significant, but still largely unknown, role in glycosphingolipid function. Potential interplay between glycolipids and their fatty acid isoforms, together with their preferential interaction with cholesterol, generates a complex mechanism for the regulation of their function in cellular physiology.

[1]  K. Sandhoff,et al.  Lysosomal lipid storage diseases. , 2011, Cold Spring Harbor perspectives in biology.

[2]  D. Lingwood,et al.  Cholesterol modulates glycolipid conformation and receptor activity. , 2011, Nature chemical biology.

[3]  C. Sweeley,et al.  Glycosphingolipids: Structure, Biological Source, and Properties , 2010 .

[4]  C. Ackerley,et al.  A Major Fraction of Glycosphingolipids in Model and Cellular Cholesterol-containing Membranes Is Undetectable by Their Binding Proteins* , 2010, The Journal of Biological Chemistry.

[5]  S. Munro,et al.  A Comprehensive Comparison of Transmembrane Domains Reveals Organelle-Specific Properties , 2010, Cell.

[6]  I. Vattulainen,et al.  Role of glycolipids in lipid rafts: a view through atomistic molecular dynamics simulations with galactosylceramide. , 2010, The journal of physical chemistry. B.

[7]  J. Lippincott-Schwartz,et al.  Lipids and cholesterol as regulators of traffic in the endomembrane system. , 2010, Annual review of biophysics.

[8]  J. Inokuchi Membrane microdomains and insulin resistance , 2010, FEBS letters.

[9]  E. Sidransky,et al.  The Role of Glucocerebrosidase Mutations in Parkinson Disease and Lewy Body Disorders , 2010, Current neurology and neuroscience reports.

[10]  P. Moreau,et al.  Glucosylceramide Biosynthesis is Involved in Golgi Morphology and Protein Secretion in Plant Cells , 2010, Traffic.

[11]  K. Simons,et al.  Structural basis of wedging the Golgi membrane by FAPP pleckstrin homology domains , 2010, EMBO reports.

[12]  J. Fantini,et al.  Altered ion channel formation by the Parkinson's-disease-linked E46K mutant of alpha-synuclein is corrected by GM3 but not by GM1 gangliosides. , 2010, Journal of molecular biology.

[13]  A. Vedani,et al.  Low molecular weight antagonists of the myelin-associated glycoprotein: synthesis, docking, and biological evaluation. , 2010, Journal of medicinal chemistry.

[14]  K. Gaus,et al.  Actin Dynamics Drive Membrane Reorganization and Scission in Clathrin-Independent Endocytosis , 2010, Cell.

[15]  J. Fantini,et al.  How Cholesterol Constrains Glycolipid Conformation for Optimal Recognition of Alzheimer's β Amyloid Peptide (Aβ1-40) , 2010, PloS one.

[16]  V. Gannon,et al.  Verocytotoxin-producing Escherichia coli (VTEC). , 2010, Veterinary microbiology.

[17]  Kai Simons,et al.  Lipid Rafts As a Membrane-Organizing Principle , 2010, Science.

[18]  K. Simons,et al.  Golgi protein FAPP2 tubulates membranes , 2009, Proceedings of the National Academy of Sciences.

[19]  J. Langston,et al.  Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: a biological link between Gaucher disease and parkinsonism. , 2009, Neurotoxicology.

[20]  M. Cabot,et al.  A New Mixed-Backbone Oligonucleotide against Glucosylceramide Synthase Sensitizes Multidrug-Resistant Tumors to Apoptosis , 2009, PloS one.

[21]  C. Lingwood,et al.  Fatty acid-dependent globotriaosyl ceramide receptor function in detergent resistant model membranes , 2009, Journal of Lipid Research.

[22]  N. Yuki,et al.  Simultaneous immunohistochemical detection of gangliosides and neuronal markers in paraformaldehyde-fixed nervous tissues by acetone etching. , 2009, Archives of histology and cytology.

[23]  K. Iwabuchi,et al.  Role of very long fatty acid-containing glycosphingolipids in membrane organization and cell signaling: the model of lactosylceramide in neutrophils , 2009, Glycoconjugate Journal.

[24]  L. Johannes,et al.  Lipid Reorganization Induced by Shiga Toxin Clustering on Planar Membranes , 2009, PloS one.

[25]  P. Lin,et al.  Lactosylceramide promotes cell migration and proliferation through activation of ERK1/2 in human aortic smooth muscle cells. , 2009, American journal of physiology. Heart and circulatory physiology.

[26]  C. Lingwood,et al.  Detergent-resistant globotriaosyl ceramide may define verotoxin/glomeruli-restricted hemolytic uremic syndrome pathology. , 2009, Kidney international.

[27]  Kai Simons,et al.  The Lipidomes of Vesicular Stomatitis Virus, Semliki Forest Virus, and the Host Plasma Membrane Analyzed by Quantitative Shotgun Mass Spectrometry , 2009, Journal of Virology.

[28]  H. Fine,et al.  SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. , 2009, Cell stem cell.

[29]  K. Handa,et al.  Specific glycosphingolipids mediate epithelial-to-mesenchymal transition of human and mouse epithelial cell lines , 2009, Proceedings of the National Academy of Sciences.

[30]  M. Langeveld,et al.  Glycosphingolipids and insulin resistance. , 2009, Progress in lipid research.

[31]  Zhenzhong Li,et al.  The neuroprotective effects of NGF combined with GM1 on injured spinal cord neurons in vitro , 2009, Brain Research Bulletin.

[32]  P. Dubbelhuis,et al.  Reducing Glycosphingolipid Content in Adipose Tissue of Obese Mice Restores Insulin Sensitivity, Adipogenesis and Reduces Inflammation , 2009, PloS one.

[33]  K. Itoh,et al.  Tyrosine Kinase Activity of Epidermal Growth Factor Receptor Is Regulated by GM3 Binding through Carbohydrate to Carbohydrate Interactions* , 2009, Journal of Biological Chemistry.

[34]  C. L. Jackson,et al.  Mechanisms of transport through the Golgi complex , 2009, Journal of Cell Science.

[35]  R. Pili,et al.  VEGF recruits lactosylceramide to induce endothelial cell adhesion molecule expression and angiogenesis in vitro and in vivo , 2009, Glycoconjugate Journal.

[36]  Takako Sasaki,et al.  Binding of laminin-1 to monosialoganglioside GM1 in lipid rafts is crucial for neurite outgrowth , 2009, Journal of Cell Science.

[37]  C. Czerkinsky,et al.  Mucosally induced Immunological Tolerance, Regulatory T Cells and the Adjuvant Effect by Cholera Toxin B Subunit , 2009, Scandinavian journal of immunology.

[38]  T. Iwamoto,et al.  Ganglioside GM1 Mediates Decapacitation Effects of SVS2 on Murine Spermatozoa1 , 2008, Biology of reproduction.

[39]  T. Hennet,et al.  The Lc3-synthase gene B3gnt5 is essential to pre-implantation development of the murine embryo , 2008, BMC Developmental Biology.

[40]  N. White,et al.  cAMP-mediated regulation of cholesterol accumulation in cystic fibrosis and Niemann-Pick type C cells. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[41]  B. Binnington,et al.  Induction of HIV-1 resistance: cell susceptibility to infection is an inverse function of globotriaosyl ceramide levels. , 2008, Glycobiology.

[42]  B. Binnington,et al.  Differential intracellular transport and binding of verotoxin 1 and verotoxin 2 to globotriaosylceramide‐containing lipid assemblies , 2008, Journal of cellular physiology.

[43]  Jyh‐cherng Yu,et al.  Expression of Globo H and SSEA3 in breast cancer stem cells and the involvement of fucosyl transferases 1 and 2 in Globo H synthesis , 2008, Proceedings of the National Academy of Sciences.

[44]  M. Wiznitzer,et al.  Ganglioside depletion and EGF responses of human GM3 synthase-deficient fibroblasts. , 2008, Glycobiology.

[45]  A. Giuliano,et al.  A role for ceramide in driving cancer cell resistance to doxorubicin , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[46]  Robert D. Phair,et al.  Transport through the Golgi Apparatus by Rapid Partitioning within a Two-Phase Membrane System , 2008, Cell.

[47]  M. Pangalos,et al.  Ganglioside Inhibition of Neurite Outgrowth Requires Nogo Receptor Function , 2008, Journal of Biological Chemistry.

[48]  G. Sapiro,et al.  Molecular architecture of native HIV-1 gp120 trimers , 2008, Nature.

[49]  T. Obrig,et al.  Immunohistologic techniques for detecting the glycolipid Gb3 in the mouse kidney and nervous system , 2008, Histochemistry and Cell Biology.

[50]  M. Langeveld,et al.  Prominent increase in plasma ganglioside GM3 is associated with clinical manifestations of type I Gaucher disease. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[51]  K. Iwabuchi,et al.  Lyn‐coupled LacCer‐enriched lipid rafts are required for CD11b/CD18‐mediated neutrophil phagocytosis of nonopsonized microorganisms , 2008, Journal of leukocyte biology.

[52]  A. Pandey,et al.  The Yin and Yang of lactosylceramide metabolism: implications in cell function. , 2008, Biochimica et biophysica acta.

[53]  S. Hakomori,et al.  Effect of lipid mimetics of GM3 and lyso-GM3 dimer on EGF receptor tyrosine kinase and EGF-induced signal transduction. , 2008, Biochimica et biophysica acta.

[54]  J. M. Aerts,et al.  Type I Gaucher disease, a glycosphingolipid storage disorder, is associated with insulin resistance. , 2008, The Journal of clinical endocrinology and metabolism.

[55]  S. Hakomori Structure and function of glycosphingolipids and sphingolipids: recollections and future trends. , 2008, Biochimica et biophysica acta.

[56]  T. Haga,et al.  Relationship between pathogenicity for humans and stx genotype in Shiga toxin-producing Escherichia coli serotype O157 , 2008, European Journal of Clinical Microbiology & Infectious Diseases.

[57]  C. Ackerley,et al.  Inhibition of Multidrug Resistance by AdamantylGb3, a Globotriaosylceramide Analog* , 2008, Journal of Biological Chemistry.

[58]  Cheng Luo,et al.  The Functional Roles of Lipid Rafts in T Cell Activation, Immune Diseases and HIV Infection and Prevention , 2008, Cellular and Molecular Immunology.

[59]  Y. Kawai,et al.  Genuine functions of P-glycoprotein (ABCB1). , 2008, Current drug metabolism.

[60]  K. Murayama,et al.  Involvement of very long fatty acid-containing lactosylceramide in lactosylceramide-mediated superoxide generation and migration in neutrophils , 2008, Glycoconjugate Journal.

[61]  P. Fratamico,et al.  Characterization of Shiga Toxin-Producing Escherichia coli Isolates Associated with Two Multistate Food-Borne Outbreaks That Occurred in 2006 , 2007, Applied and Environmental Microbiology.

[62]  Katharina Gaus,et al.  Shiga toxin induces tubular membrane invaginations for its uptake into cells , 2007, Nature.

[63]  I. Singh,et al.  Lactosylceramide: a lipid second messenger in neuroinflammatory disease , 2007, Journal of neurochemistry.

[64]  J. Fantini Interaction of proteins with lipid rafts through glycolipid-binding domains: biochemical background and potential therapeutic applications. , 2007, Current medicinal chemistry.

[65]  M. Latterich,et al.  Requirements for the selective degradation of CD4 receptor molecules by the human immunodeficiency virus type 1 Vpu protein in the endoplasmic reticulum , 2007, Retrovirology.

[66]  G. van Meer,et al.  Pre- and post-Golgi translocation of glucosylceramide in glycosphingolipid synthesis , 2007, The Journal of cell biology.

[67]  M. Doyle,et al.  Food as a vehicle for transmission of Shiga toxin-producing Escherichia coli. , 2007, Journal of food protection.

[68]  T. D. Connell,et al.  Cholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by Type I and Type II heat-labile enterotoxins , 2007, Expert review of vaccines.

[69]  Y. Hannun,et al.  Glycosphingolipid synthesis requires FAPP2 transfer of glucosylceramide , 2007, Nature.

[70]  D. Lingwood,et al.  Detergent resistance as a tool in membrane research , 2007, Nature Protocols.

[71]  Y. Igarashi,et al.  Dissociation of the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistance , 2007, Proceedings of the National Academy of Sciences.

[72]  S. O’Rahilly,et al.  Pharmacological Inhibition of Glucosylceramide Synthase Enhances Insulin Sensitivity , 2007, Diabetes.

[73]  Seng H. Cheng,et al.  Inhibiting Glycosphingolipid Synthesis Improves Glycemic Control and Insulin Sensitivity in Animal Models of Type 2 Diabetes , 2007, Diabetes.

[74]  Jinjun Shi,et al.  GM1 clustering inhibits cholera toxin binding in supported phospholipid membranes. , 2007, Journal of the American Chemical Society.

[75]  A. Schnitzler,et al.  Induction of Cell Signaling Events by the Cholera Toxin B Subunit in Antigen-Presenting Cells , 2007, Infection and Immunity.

[76]  R. Perlingeiro,et al.  SSEA-4 identifies mesenchymal stem cells from bone marrow. , 2007, Blood.

[77]  T. Schulz,et al.  The Cell Surface Glycosphingolipids SSEA‐3 and SSEA‐4 Are Not Essential for Human ESC Pluripotency , 2007, Stem cells.

[78]  M. Cabot,et al.  Glycosphingolipids and drug resistance. , 2006, Biochimica et biophysica acta.

[79]  T. Hikita,et al.  Epidermal growth factor receptor tyrosine kinase is modulated by GM3 interaction with N-linked GlcNAc termini of the receptor , 2006, Proceedings of the National Academy of Sciences.

[80]  E. Gazit,et al.  The minimal amyloid‐forming fragment of the islet amyloid polypeptide is a glycolipid‐binding domain , 2006, The FEBS journal.

[81]  R. Abagyan,et al.  The Liganding of Glycolipid Transfer Protein Is Controlled by Glycolipid Acyl Structure , 2006, PLoS biology.

[82]  S. V. van IJzendoorn,et al.  Efficient trafficking of MDR1/P-glycoprotein to apical canalicular plasma membranes in HepG2 cells requires PKA-RIIalpha anchoring and glucosylceramide. , 2006, Molecular biology of the cell.

[83]  K. Kaibuchi,et al.  Myelin-associated Glycoprotein Inhibits Microtubule Assembly by a Rho-kinase-dependent Mechanism* , 2006, Journal of Biological Chemistry.

[84]  Chiou-Feng Lin,et al.  Ceramide in apoptotic signaling and anticancer therapy. , 2006, Current medicinal chemistry.

[85]  J. Medin,et al.  Treatment of neutral glycosphingolipid lysosomal storage diseases via inhibition of the ABC drug transporter, MDR1 , 2006, The FEBS journal.

[86]  Kazuro Furukawa,et al.  Targeted Disruption of Gb3/CD77 Synthase Gene Resulted in the Complete Deletion of Globo-series Glycosphingolipids and Loss of Sensitivity to Verotoxins* , 2006, Journal of Biological Chemistry.

[87]  I. Wilson,et al.  Design of natural killer T cell activators: structure and function of a microbial glycosphingolipid bound to mouse CD1d. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[88]  John R. Riordan,et al.  Misassembled mutant ΔF508 CFTR in the distal secretory pathway alters cellular lipid trafficking , 2006, Journal of Cell Science.

[89]  R. Blumenthal,et al.  A novel soluble mimic of the glycolipid, globotriaosyl ceramide inhibits HIV infection , 2006, AIDS.

[90]  M. Bennish,et al.  Low risk of hemolytic uremic syndrome after early effective antimicrobial therapy for Shigella dysenteriae type 1 infection in Bangladesh. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[91]  M. Del Poeta,et al.  Role of Sphingolipids in Microbial Pathogenesis , 2006, Infection and Immunity.

[92]  L. Johannes,et al.  Article Title: the Association of Shiga-like Toxin with Detergent-resistant Membranes Is Modulated by Glucosylceramide and Is an Essential Requirement in the Endoplasmic Reticulum for a Cytotoxic Effect the Association of Shiga-like Toxin with Detergent- Resistant Membranes Is Modulated by Glucosylc , 2022 .

[93]  R. Brady,et al.  Lack of susceptibility of cells from patients with Fabry disease to productive infection with R5 human immunodeficiency virus , 2005, AIDS.

[94]  K. Sandvig,et al.  The A‐subunit of surface‐bound Shiga toxin stimulates clathrin‐dependent uptake of the toxin , 2005, The FEBS journal.

[95]  S. Stice,et al.  Lectin binding profiles of SSEA-4 enriched, pluripotent human embryonic stem cell surfaces , 2005, BMC Developmental Biology.

[96]  F. Sharom,et al.  The reconstituted P-glycoprotein multidrug transporter is a flippase for glucosylceramide and other simple glycosphingolipids. , 2005, The Biochemical journal.

[97]  S. Krämer,et al.  Effect of the modulation of the membrane lipid composition on the localization and function of P-glycoprotein in MDR1-MDCK cells , 2005, In Vitro Cellular & Developmental Biology - Animal.

[98]  T. D. Connell,et al.  Differential Binding of Escherichia coli Enterotoxins LT-IIa and LT-IIb and of Cholera Toxin Elicits Differences in Apoptosis, Proliferation, and Activation of Lymphoid Cells , 2005, Infection and Immunity.

[99]  J. Paulson,et al.  Potent Glycan Inhibitors of Myelin-associated Glycoprotein Enhance Axon Outgrowth in Vitro* , 2005, Journal of Biological Chemistry.

[100]  I. Singh,et al.  A novel role of lactosylceramide in the regulation of tumor necrosis factor alpha-mediated proliferation of rat primary astrocytes. Implications for astrogliosis following neurotrauma. , 2005, The Journal of biological chemistry.

[101]  David L. Swerdlow,et al.  Epidemiology of Escherichia coli O157:H7 Outbreaks, United States, 1982–2002 , 2005, Emerging infectious diseases.

[102]  Manuel Prieto,et al.  Lipid rafts have different sizes depending on membrane composition: a time-resolved fluorescence resonance energy transfer study. , 2005, Journal of molecular biology.

[103]  R. Proia,et al.  Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[104]  M. Schlossmacher,et al.  The glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews. , 2005, The New England journal of medicine.

[105]  E. Ikonen,et al.  Lipid Microdomains and Insulin Resistance: Is There a Connection? , 2005, Science's STKE.

[106]  Perttu S. Niemelä,et al.  Structure and dynamics of sphingomyelin bilayer: insight gained through systematic comparison to phosphatidylcholine. , 2004, Biophysical journal.

[107]  R. Dwek,et al.  Cellular effects of deoxynojirimycin analogues: uptake, retention and inhibition of glycosphingolipid biosynthesis. , 2004, The Biochemical journal.

[108]  R. Dwek,et al.  Treatment with miglustat reverses the lipid-trafficking defect in Niemann–Pick disease type C , 2004, Neurobiology of Disease.

[109]  N. White,et al.  Mechanistic similarities between cultured cell models of cystic fibrosis and niemann-pick type C. , 2004, American journal of respiratory cell and molecular biology.

[110]  Peter Strålfors,et al.  Colocalization of insulin receptor and insulin receptor substrate-1 to caveolae in primary human adipocytes. Cholesterol depletion blocks insulin signalling for metabolic and mitogenic control. , 2004, European journal of biochemistry.

[111]  M. Gottesman,et al.  Overexpression of glucosylceramide synthase and P-glycoprotein in cancer cells selected for resistance to natural product chemotherapy. , 2004, Molecular cancer therapeutics.

[112]  I. Mills,et al.  Clathrin adaptor epsinR is required for retrograde sorting on early endosomal membranes. , 2004, Developmental cell.

[113]  C. Ackerley,et al.  Role of Multiple Drug Resistance Protein 1 in Neutral but Not Acidic Glycosphingolipid Biosynthesis* , 2004, Journal of Biological Chemistry.

[114]  K. Ravichandran,et al.  Human Immunodeficiency Virus Type 1 Nef Associates with Lipid Rafts To Downmodulate Cell Surface CD4 and Class I Major Histocompatibility Complex Expression and To Increase Viral Infectivity , 2004, Journal of Virology.

[115]  Y. Wada,et al.  Sulfatide is a negative regulator of oligodendrocyte differentiation: Development in sulfatide‐null mice , 2004, Glia.

[116]  J. Pettegrew,et al.  Alzheimer's Disease: NMR Studies of Asialo (GM1) and Trisialo (GT1b) Ganglioside Interactions with Aβ(1-40) Peptide in a Membrane Mimic Environment , 2004, Neurochemical Research.

[117]  A. Verkman,et al.  CFTR pharmacology and its role in intestinal fluid secretion. , 2003, Current opinion in pharmacology.

[118]  R. Steffensen,et al.  Two Distinct Gb3/CD77 Signaling Pathways Leading to Apoptosis Are Triggered by Anti-Gb3/CD77 mAb and Verotoxin-1* , 2003, Journal of Biological Chemistry.

[119]  U. Buchholz,et al.  Strong Association Between Shiga Toxin-Producing Escherichia coli O157 and Virulence Genes stx2 and eae as Possible Explanation for Predominance of Serogroup O157 in Patients with Haemolytic Uraemic Syndrome , 2003, European Journal of Clinical Microbiology and Infectious Diseases.

[120]  T. Wada,et al.  Human α2,3-Sialyltransferase (ST3Gal II) Is a Stage-specific Embryonic Antigen-4 Synthase* , 2003, Journal of Biological Chemistry.

[121]  I. Wilson,et al.  Crystal structure of CD1a in complex with a sulfatide self antigen at a resolution of 2.15 Å , 2003, Nature Immunology.

[122]  V. Puri,et al.  Sphingolipid Storage Induces Accumulation of Intracellular Cholesterol by Stimulating SREBP-1 Cleavage* , 2003, Journal of Biological Chemistry.

[123]  R. Pagano Endocytic trafficking of glycosphingolipids in sphingolipid storage diseases. , 2003, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[124]  G. Hoser,et al.  Structure of the ceramide moiety of GM1 ganglioside determines its occurrence in different detergent-resistant membrane domains in HL-60 cells. , 2003, Biochemistry.

[125]  T. Yutsudo,et al.  Rapid Apoptosis Induced by Shiga Toxin in HeLa Cells , 2003, Infection and Immunity.

[126]  L. Johannes,et al.  Effects of HIV‐1 Nef on Retrograde Transport from the Plasma Membrane to the Endoplasmic Reticulum , 2003, Traffic.

[127]  P. Loll Membrane protein structural biology: the high throughput challenge. , 2003, Journal of structural biology.

[128]  R. Proia,et al.  Enhanced insulin sensitivity in mice lacking ganglioside GM3 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[129]  C. Haass,et al.  Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts , 2003, The Journal of cell biology.

[130]  R. Proia,et al.  Early developmental expression of the gene encoding glucosylceramide synthase, the enzyme controlling the first committed step of glycosphingolipid synthesis. , 2002, Biochimica et biophysica acta.

[131]  C. Bandtlow,et al.  Nogo-A and Myelin-Associated Glycoprotein Mediate Neurite Growth Inhibition by Antagonistic Regulation of RhoA and Rac1 , 2002, The Journal of Neuroscience.

[132]  R. Dwek,et al.  Glucosylceramide modulates membrane traffic along the endocytic pathway Published, JLR Papers in Press, August 16, 2002. DOI 10.1194/jlr.M200232-JLR200 , 2002, Journal of Lipid Research.

[133]  J. Fantini,et al.  A novel soluble analog of the HIV-1 fusion cofactor, globotriaosylceramide (Gb3), eliminates the cholesterol requirement for high affinity gp120/Gb3 interaction DOI 10.1194/jlr.M200165-JLR200 , 2002, Journal of Lipid Research.

[134]  M. Schachner,et al.  Gangliosides are functional nerve cell ligands for myelin-associated glycoprotein (MAG), an inhibitor of nerve regeneration , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[135]  W. Au,et al.  Human Immunodeficiency Virus Type 1 Uses Lipid Raft-Colocalized CD4 and Chemokine Receptors for Productive Entry into CD4+ T Cells , 2002, Journal of Virology.

[136]  D. Acheson,et al.  Hemolytic uremic syndrome: epidemiology, pathophysiology, and therapy , 2002, Pediatric Nephrology.

[137]  J. Fantini,et al.  Identification of a Common Sphingolipid-binding Domain in Alzheimer, Prion, and HIV-1 Proteins* , 2002, The Journal of Biological Chemistry.

[138]  K. Fukushima,et al.  Paranodal junction formation and spermatogenesis require sulfoglycolipids , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[139]  M. Jobling,et al.  Mutational Analysis of Ganglioside GM1-Binding Ability, Pentamer Formation, and Epitopes of Cholera Toxin B (CTB) Subunits and CTB/Heat-Labile Enterotoxin B Subunit Chimeras , 2002, Infection and Immunity.

[140]  C. MacKenzie,et al.  A Mutational Analysis of the Globotriaosylceramide-binding Sites of Verotoxin VT1* , 2002, The Journal of Biological Chemistry.

[141]  D. Kabat,et al.  Segregation of CD4 and CXCR4 into Distinct Lipid Microdomains in T Lymphocytes Suggests a Mechanism for Membrane Destabilization by Human Immunodeficiency Virus , 2002, Journal of Virology.

[142]  Y. Igarashi,et al.  Ganglioside GM3 Participates in the Pathological Conditions of Insulin Resistance* , 2002, The Journal of Biological Chemistry.

[143]  T. Suzuki,et al.  Different binding property of verotoxin-1 and verotoxin-2 against their glycolipid receptor, globotriaosylceramide. , 2001, The Tohoku journal of experimental medicine.

[144]  E. Freed,et al.  Plasma membrane rafts play a critical role in HIV-1 assembly and release , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[145]  H Nakajima,et al.  Kinetic Analysis of Binding between Shiga Toxin and Receptor Glycolipid Gb3Cer by Surface Plasmon Resonance* , 2001, The Journal of Biological Chemistry.

[146]  B. Westerink,et al.  UvA-DARE ( Digital Academic Repository ) Glycosphingolipids are required for sorting melanosomal proteins in the Golgi complex , 2001 .

[147]  Yoshimasa Kinoshita,et al.  Toxicity of Shiga Toxin 1 in the Central Nervous System of Rabbits , 2001, Infection and Immunity.

[148]  P. Ray,et al.  Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome , 2001, Pediatric Nephrology.

[149]  A. Abe,et al.  Agents for the treatment of glycosphingolipid storage disorders. , 2001, Current drug metabolism.

[150]  J. Salamero,et al.  Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes. , 2001, Molecular biology of the cell.

[151]  Dzung H. Nguyen,et al.  Lipid rafts and HIV pathogenesis: host membrane cholesterol is required for infection by HIV type 1. , 2001, AIDS research and human retroviruses.

[152]  G. Millat,et al.  Niemann-Pick type C disease: NPC1 mutations associated with severe and mild cellular cholesterol trafficking alterations , 2001, Human Genetics.

[153]  S. Wied,et al.  Redistribution of Glycolipid Raft Domain Components Induces Insulin-Mimetic Signaling in Rat Adipocytes , 2001, Molecular and Cellular Biology.

[154]  J. Lippincott-Schwartz,et al.  Rapid Cycling of Lipid Raft Markers between the Cell Surface and Golgi Complex , 2001, The Journal of cell biology.

[155]  A. Zurita,et al.  Modulation of epidermal growth factor receptor phosphorylation by endogenously expressed gangliosides. , 2001, The Biochemical journal.

[156]  A. Giuliano,et al.  Ceramide glycosylation potentiates cellular multidrug resistance , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[157]  T. Suzuki,et al.  Globotriaosyl ceramide (CD77/Gb3) in the glycolipid-enriched membrane domain participates in B-cell receptor-mediated apoptosis by regulating lyn kinase activity in human B cells. , 2000, Experimental hematology.

[158]  C. Martínez-A,et al.  Membrane raft microdomains mediate lateral assemblies required for HIV‐1 infection , 2000, EMBO reports.

[159]  T. Hikita,et al.  Requirement of Seminolipid in Spermatogenesis Revealed by UDP-galactose:Ceramide Galactosyltransferase-deficient Mice* , 2000, The Journal of Biological Chemistry.

[160]  Dzung H. Nguyen,et al.  Evidence for Budding of Human Immunodeficiency Virus Type 1 Selectively from Glycolipid-Enriched Membrane Lipid Rafts , 2000, Journal of Virology.

[161]  R. Dwek,et al.  N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo. , 2000, Biochemical pharmacology.

[162]  V. Herzog,et al.  Cholera Toxin Is Exported from Microsomes by the Sec61p Complex , 2000, The Journal of cell biology.

[163]  C. Lingwood,et al.  Retroviral Transfection of Madin-Darby Canine Kidney Cells with Human MDR1 Results in a Major Increase in Globotriaosylceramide and 105- to 106-Fold Increased Cell Sensitivity to Verocytotoxin , 2000, The Journal of Biological Chemistry.

[164]  M. Kuriyama,et al.  Unglycosylated Trk protein does not co-localize nor associate with ganglioside GM1 in stable clone of PC12 cells overexpressing Trk (PCtrk cells) , 2000, Glycoconjugate Journal.

[165]  J. Fantini,et al.  Role of glycosphingolipid microdomains in CD4-dependent HIV-1 fusion , 2000, Glycoconjugate Journal.

[166]  Y. Sanai,et al.  Functional roles of glycosphingolipids in signal transduction via lipid rafts , 2000, Glycoconjugate Journal.

[167]  J. Boggs,et al.  Trans interactions between galactosylceramide and cerebroside sulfate across apposed bilayers. , 2000, Biophysical journal.

[168]  A. Saltiel,et al.  Signaling pathways in insulin action: molecular targets of insulin resistance. , 2000, The Journal of clinical investigation.

[169]  Tetsuya Mori,et al.  Activation of Src Family Kinase Yes Induced by Shiga Toxin Binding to Globotriaosyl Ceramide (Gb3/CD77) in Low Density, Detergent-insoluble Microdomains* , 1999, The Journal of Biological Chemistry.

[170]  G. Kopf,et al.  Cholesterol efflux-mediated signal transduction in mammalian sperm: cholesterol release signals an increase in protein tyrosine phosphorylation during mouse sperm capacitation. , 1999, Developmental biology.

[171]  V. Puri,et al.  Cholesterol modulates membrane traffic along the endocytic pathway in sphingolipid-storage diseases , 1999, Nature Cell Biology.

[172]  M. Patterson,et al.  Broad screening test for sphingolipid-storage diseases , 1999, The Lancet.

[173]  J. Sodroski,et al.  Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic. , 1999, Biochemistry.

[174]  J. Fantini,et al.  Human Erythrocyte Glycosphingolipids as Alternative Cofactors for Human Immunodeficiency Virus Type 1 (HIV-1) Entry: Evidence for CD4-Induced Interactions between HIV-1 gp120 and Reconstituted Membrane Microdomains of Glycosphingolipids (Gb3 and GM3) , 1999, Journal of Virology.

[175]  D. Acheson,et al.  Responses of Human Intestinal Microvascular Endothelial Cells to Shiga Toxins 1 and 2 and Pathogenesis of Hemorrhagic Colitis , 1999, Infection and Immunity.

[176]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[177]  S. Siziya,et al.  Predictors of mortality in children hospitalized with dysentery in Harare, Zimbabwe. , 1998, The Central African journal of medicine.

[178]  J. Slot,et al.  UDP-Galactose:Ceramide Galactosyltransferase Is a Class I Integral Membrane Protein of the Endoplasmic Reticulum* , 1998, The Journal of Biological Chemistry.

[179]  J. Schneider GM1 Ganglioside in the Treatment of Parkinson's Disease a , 1998 .

[180]  James L. Madara,et al.  Ganglioside Structure Dictates Signal Transduction by Cholera Toxin and Association with Caveolae-like Membrane Domains in Polarized Epithelia , 1998, The Journal of cell biology.

[181]  J. Fantini,et al.  Sequential interaction of CD4 and HIV-1 gp120 with a reconstituted membrane patch of ganglioside GM3: implications for the role of glycolipids as potential HIV-1 fusion cofactors. , 1998, Biochemical and biophysical research communications.

[182]  A. Ljungh,et al.  The lactosylceramide binding specificity of Helicobacter pylori. , 1998, Glycobiology.

[183]  A. Stringaro,et al.  Detection of P‐glycoprotein in the Golgi apparatus of drug‐untreated human melanoma cells , 1998, International journal of cancer.

[184]  A. Blight,et al.  Myelin Galactolipids Are Essential for Proper Node of Ranvier Formation in the CNS , 1998, The Journal of Neuroscience.

[185]  B. Popko,et al.  New perspectives on the function of myelin galactolipids , 1998, Trends in Neurosciences.

[186]  Y. Ihara,et al.  GM1 Ganglioside-Bound Amyloid β-Protein in Alzheimer’s Disease Brain , 1998, Neurobiology of Aging.

[187]  R J Read,et al.  Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3. , 1998, Biochemistry.

[188]  R. Lal,et al.  CCR5 coreceptor usage of non-syncytium-inducing primary HIV-1 is independent of phylogenetically distinct global HIV-1 isolates: delineation of consensus motif in the V3 domain that predicts CCR-5 usage. , 1998, Virology.

[189]  J. Fantini,et al.  Synthetic Soluble Analogs of Galactosylceramide (GalCer) Bind to the V3 Domain of HIV-1 gp120 and Inhibit HIV-1-induced Fusion and Entry* , 1997, The Journal of Biological Chemistry.

[190]  K. Karlsson,et al.  Screening for the presence of polyglycosylceramides in various tissues: partial characterization of blood group-active complex glycosphingolipids of rabbit and dog small intestines , 1997, Glycoconjugate Journal.

[191]  J. Fantini,et al.  SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids. , 1996, Biochemistry.

[192]  Joseph Sodroski,et al.  CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5 , 1996, Nature.

[193]  K. Takamiya,et al.  Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[194]  C. Lingwood Aglycone modulation of glycolipid receptor function , 1996, Glycoconjugate Journal.

[195]  A. Blight,et al.  Myelination in the Absence of Galactocerebroside and Sulfatide: Normal Structure with Abnormal Function and Regional Instability , 1996, Cell.

[196]  J. Boggs,et al.  Study by infrared spectroscopy of the interdigitation of C26:0 cerebroside sulfate into phosphatidylcholine bilayers. , 1996, Biochemistry.

[197]  T. Koerner,et al.  Multiple glycosphingolipids determine the tissue tropism of parvovirus B19. , 1995, The Journal of infectious diseases.

[198]  S. Hakomori,et al.  Galactosylgloboside expression in seminoma. Inverse correlation with metastatic potential , 1995, Cancer.

[199]  M. Hamaguchi,et al.  Ganglioside GM1 binds to the Trk protein and regulates receptor function. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[200]  P. Spitalnik,et al.  The P blood group system: biochemical, serological, and clinical aspects. , 1995, Transfusion medicine reviews.

[201]  S. Lawson,et al.  Substance P, neurofilament, peripherin and SSEA4 immunocytochemistry of human dorsal root ganglion neurons obtained from post-mortem tissue: a quantitative morphometric analysis , 1994, Journal of neurocytology.

[202]  C. Lingwood,et al.  Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues. , 1994, The Journal of biological chemistry.

[203]  F. Wieland,et al.  Lactosylceramide is synthesized in the lumen of the Golgi apparatus , 1994, FEBS letters.

[204]  H. Jarrell,et al.  Acyl chain length effects related to glycosphingolipid crypticity in phospholipid membranes: probed by 2H-NMR. , 1994, Biochimica et biophysica acta.

[205]  J. Martial,et al.  Crystal structure of cholera toxin B‐pentamer bound to receptor GM1 pentasaccharide , 1994, Protein science : a publication of the Protein Society.

[206]  S. Hakomori,et al.  GM3 directly inhibits tyrosine phosphorylation and de-N-acetyl-GM3 directly enhances serine phosphorylation of epidermal growth factor receptor, independently of receptor-receptor interaction. , 1994, The Journal of biological chemistry.

[207]  J. Boggs,et al.  Do the long fatty acid chains of sphingolipids interdigitate across the center of a bilayer of shorter chain symmetric phospholipids? , 1994, Biochimica et biophysica acta.

[208]  K. Karlsson,et al.  New method for the isolation of polyglycosylceramides from human erythrocyte membranes. , 1993, Biochimica et biophysica acta.

[209]  G. Guroff,et al.  The Effect of the B Subunit of Cholera Toxin on the Action of Nerve Growth Factor on PC12 Cells , 1993, Journal of neurochemistry.

[210]  J. Fantini,et al.  Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[211]  D. Weiner,et al.  The galactosyl ceramide/sulfatide receptor binding region of HIV-1 gp120 maps to amino acids 206-275. , 1993, AIDS research and human retroviruses.

[212]  H. Moreau,et al.  Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells , 1992, Journal of virology.

[213]  P. Fishman,et al.  Intoxication of cultured cells by cholera toxin: evidence for different pathways when bound to ganglioside GM1 or neoganglioproteins. , 1992, Biochemistry.

[214]  F. Wieland,et al.  Glucosylceramide is synthesized at the cytosolic surface of various Golgi subfractions , 1992, The Journal of cell biology.

[215]  A. Abe,et al.  Improved inhibitors of glucosylceramide synthase. , 1992, The Journal of biological chemistry.

[216]  R. Pagano,et al.  Determination of the intracellular sites and topology of glucosylceramide synthesis in rat liver. , 1991, The Biochemical journal.

[217]  D. Silberberg,et al.  Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[218]  P. Fishman,et al.  Neoglycolipid analogues of ganglioside GM1 as functional receptors of cholera toxin. , 1991, Biochemistry.

[219]  K. Karlsson,et al.  Characterization of the binding of propionibacterium granulosum to glycosphingolipids adsorbed on surfaces. An apparent recognition of lactose which is dependent on the ceramide structure. , 1990, The Journal of biological chemistry.

[220]  H. Jarrell,et al.  Glycosphingolipid interdigitation in phospholipid bilayers examined by deuterium NMR and EPR. , 1990, Biochimica et biophysica acta.

[221]  J. Boggs,et al.  Dependence of the surface expression of the glycolipid cerebroside sulfate on its lipid environment: comparison of sphingomyelin and phosphatidylcholine. , 1990, Biochemistry.

[222]  N. Radin,et al.  Effects of D‐threo‐PDMP, an inhibitor of glucosylceramide synthetase, on expression of cell surface glycolipid antigen and binding to adhesive proteins by B16 melanoma cells , 1989, Journal of cellular physiology.

[223]  L. Wolpert Positional information revisited. , 1989, Development.

[224]  P. Oteiza,et al.  Inhibition of the synthesis of glycosphingolipids affects the translocation of proteolipid protein to the myelin membrane , 1989, Journal of neuroscience research.

[225]  S. Saxena,et al.  Shiga toxin, Shiga-like toxin II variant, and ricin are all single-site RNA N-glycosidases of 28 S RNA when microinjected into Xenopus oocytes. , 1989, The Journal of biological chemistry.

[226]  I. Pascher,et al.  On the dissection of binding epitopes on carbohydrate receptors for microbes using molecular modelling. , 1988, Biochimie.

[227]  A. Ullrich,et al.  Biological activities of EGF‐receptor mutants with individually altered autophosphorylation sites. , 1988, The EMBO journal.

[228]  S. Hakomori,et al.  A novel ganglioside, de-N-acetyl-GM3 (II3NeuNH2LacCer), acting as a strong promoter for epidermal growth factor receptor kinase and as a stimulator for cell growth. , 1988, The Journal of biological chemistry.

[229]  P. Andrews Human teratocarcinoma stem cells: Glycolipid antigen expression and modulation during differentiation , 1987, Journal of cellular biochemistry.

[230]  G van Meer,et al.  Sorting of sphingolipids in epithelial (Madin-Darby canine kidney) cells , 1987, The Journal of cell biology.

[231]  D. Solter,et al.  Detection of SSEA‐1 on human renal tumors , 1987, Cancer.

[232]  F. Inagaki,et al.  A new extended globoglycolipid carrying the stage specific embryonic antigen-1 (SSEA-1) determinant in mouse kidney. , 1987, Journal of biochemistry.

[233]  J. Boggs,et al.  Factors affecting surface expression of glycolipids: influence of lipid environment and ceramide composition on antibody recognition of cerebroside sulfate in liposomes. , 1986, Biochemistry.

[234]  C. Lingwood Timing of sulphogalactolipid biosynthesis in the rat testis studied by tissue autoradiography. , 1985, Journal of cell science.

[235]  T. Jessell,et al.  Structure and expression of differentiation antigens on functional subclasses of primary sensory neurons , 1985, Philosophical Transactions of the Royal Society of London. B, Biological Sciences.

[236]  S. Hakomori,et al.  Enzymatic and organizational difference in expression of a Burkitt lymphoma-associated antigen (globotriaosylceramide) in Burkitt lymphoma and lymphoblastoid cell lines. , 1984, The Journal of biological chemistry.

[237]  D. Solter,et al.  Stage‐specific embryonic antigens (SSEA‐3 and ‐4) are epitopes of a unique globo‐series ganglioside isolated from human teratocarcinoma cells. , 1983, The EMBO journal.

[238]  S. Hakomori,et al.  Factors affecting expression of glycolipid tumor antigens: influence of ceramide composition and coexisting glycolipid on the antigenicity of gangliotriaosylceramide in murine lymphoma cells. , 1983, Cancer research.

[239]  E. Carey,et al.  UDP‐Galactose:Ceramide Galactosyl Transferase of Isolated Oligodendroglia , 1983, Journal of neurochemistry.

[240]  S. Hakomori,et al.  A series of human erythrocyte glycosphingolipids reacting to the monoclonal antibody directed to a developmentally regulated antigen SSEA-1. , 1982, The Journal of biological chemistry.

[241]  D. Solter,et al.  Murine embryonic antigen (SSEA-1) is expressed on human cells and structurally related human blood group antigen I is expressed on mouse embryos. , 1982, Developmental biology.

[242]  D. Solter,et al.  Monoclonal antibody against SSEA-1 is specific for a subpopulation of astrocytes in mouse cerebellum , 1982, Neuroscience Letters.

[243]  D. Solter,et al.  Immunohistochemical localization of murine stage-specific embryonic antigens in human testicular germ cell tumors. , 1982, The American journal of pathology.

[244]  S. Hakomori,et al.  Possible role of ceramide in defining structure and function of membrane glycolipids. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[245]  D. Solter,et al.  A murine stage-specific embryonic antigen (SSEA-2) is expressed on some murine SV40-transformed cells. , 1981, Journal of Immunology.

[246]  D. Solter,et al.  Immunohistochemical localization of the early embryonic antigen (SSEA-1) in postimplantation mouse embryos and fetal and adult tissues. , 1981, Developmental biology.

[247]  D. Solter,et al.  Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[248]  D. Gill,et al.  ADP-ribosylation of membrane proteins catalyzed by cholera toxin: basis of the activation of adenylate cyclase. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[249]  I. Pascher,et al.  Molecular arrangements in sphingolipids. The crystal structure of cerebroside , 1977 .

[250]  S. Hakomori,et al.  Selective inhibition of cell growth and associated changes in glycolipid metabolism induced by monovalent antibodies to glycolipids. , 1977, Experimental cell research.

[251]  Gill Dm The arrangement of subunits in cholera toxin. , 1976 .

[252]  D. Summerbell,et al.  Positional signalling and specification of digits in chick limb morphogenesis , 1975, Nature.

[253]  S. Heyningen,et al.  Cholera Toxin: Interaction of Subunits with Ganglioside GM1 , 1974 .

[254]  김종선 On the mechanism of internalization of alpha-synuclein into microglia: roles of ganglioside GM1 and lipid raft , 2009 .

[255]  R. McElhaney,et al.  Calorimetric and spectroscopic studies of the effects of cholesterol on the thermotropic phase behavior and organization of a homologous series of linear saturated phosphatidylglycerol bilayer membranes. , 2009, Biochimica et biophysica acta.

[256]  P. Galle,et al.  The longevity assurance homologue of yeast lag1 (Lass) gene family (review). , 2009, International journal of molecular medicine.

[257]  K. Murayama,et al.  Involvement of very long fatty acid-containing lactosylceramide in lactosylceramide-mediated superoxide generation and migration in neutrophils , 2008, Glycoconjugate Journal.

[258]  L. Johannes,et al.  The secretion inhibitor Exo 2 perturbs trafficking of Shiga toxin between endosomes and the trans-Golgi network , 2008 .

[259]  W. Lencer,et al.  Rafting with cholera toxin: endocytosis and trafficking from plasma membrane to ER. , 2007, FEMS microbiology letters.

[260]  A. Varki,et al.  Siglecs--the major subfamily of I-type lectins. , 2006, Glycobiology.

[261]  Xianlin Han Lipid alterations in the earliest clinically recognizable stage of Alzheimer's disease: implication of the role of lipids in the pathogenesis of Alzheimer's disease. , 2005, Current Alzheimer research.

[262]  C. Lingwood,et al.  Verotoxin sensitivity of ECV304 cells in vitro and in vivo in a xenograft tumour model: VT1 as a tumour neovascular marker , 2004, Angiogenesis.

[263]  C. Lingwood,et al.  Differential carbohydrate epitope recognition of globotriaosyl ceramide by verotoxins and a monoclonal antibody. , 2004, European journal of biochemistry.

[264]  T. Muramatsu,et al.  Carbohydrate antigens expressed on stem cells and early embryonic cells , 2004, Glycoconjugate Journal.

[265]  R. Proia,et al.  A vital role for glycosphingolipid synthesis during development and differentiation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[266]  M. Foti,et al.  The HIV-1 Nef protein acts as a connector with sorting pathways in the Golgi and at the plasma membrane. , 1997, Immunity.

[267]  L. Greene,et al.  Prevention of neuronal apoptotic death by neurotrophic agents and ganglioside GM1: insights and speculations regarding a common mechanism. , 1996, Perspectives on developmental neurobiology.

[268]  Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. , 1991, Disease markers.

[269]  M. Ferguson,et al.  Cell-surface anchoring of proteins via glycosyl-phosphatidylinositol structures. , 1988, Annual review of biochemistry.

[270]  S. Hakomori Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. , 1981, Annual review of biochemistry.

[271]  L Orci,et al.  Heterogeneous distribution of filipin--cholesterol complexes across the cisternae of the Golgi apparatus. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[272]  A. Kahn,et al.  The Cell Surface , 1974, Advances in Experimental Medicine and Biology.